These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32515342)

  • 21. Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan.
    Ishida W; Kajiwara T; Ishii M; Fujiwara F; Taneichi H; Takebe N; Takahashi K; Kaneko Y; Segawa I; Inoue H; Satoh J
    Tohoku J Exp Med; 2007 Jul; 212(3):265-73. PubMed ID: 17592214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
    Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between statins and COPD: a systematic review.
    Dobler CC; Wong KK; Marks GB
    BMC Pulm Med; 2009 Jul; 9():32. PubMed ID: 19594891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids.
    Huang YJ; Kao S; Kao LT; Chian CF; Chung CH; Chien WC; Wang KY
    Int J Chron Obstruct Pulmon Dis; 2021; 16():591-602. PubMed ID: 33716501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pleiotropic Effects of Rosuvastatin in Chronic Obstructive Pulmonary Disease Patients With High Cardiovascular Risk].
    Samorukova EI; Adasheva TV; Zadionchenko VS; Rosliakova GA
    Kardiologiia; 2015; 55(7):32-7. PubMed ID: 26688923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.
    van Gestel YR; Hoeks SE; Sin DD; Simsek C; Welten GM; Schouten O; Stam H; Mertens FW; van Domburg RT; Poldermans D
    Am J Cardiol; 2008 Jul; 102(2):192-6. PubMed ID: 18602520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
    JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.
    Rossi A; Inciardi RM; Rossi A; Temporelli PL; Lucci D; Gonzini L; Marchioli R; Nicolosi GL; Tavazzi L;
    Pulm Pharmacol Ther; 2017 Jun; 44():16-23. PubMed ID: 28263812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chou KT; Lin SJ; Chen JW; Leu HB
    Clin Ther; 2011 Oct; 33(10):1365-70. PubMed ID: 21962452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic manifestations and comorbidities of COPD.
    Barnes PJ; Celli BR
    Eur Respir J; 2009 May; 33(5):1165-85. PubMed ID: 19407051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.
    Cazzola M; Calzetta L; Rinaldi B; Page C; Rosano G; Rogliani P; Matera MG
    Drugs; 2017 May; 77(7):721-732. PubMed ID: 28349353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic obstructive pulmonary disease and cardiovascular diseases].
    Passowicz-Muszyńska E; Gostkowska-Malec A; Jankowska R; Piesiak P
    Pneumonol Alergol Pol; 2010; 78(1):28-32. PubMed ID: 20162516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of long-term using statins in COPD - a network meta-analysis.
    Lu Y; Chang R; Yao J; Xu X; Teng Y; Cheng N
    Respir Res; 2019 Jan; 20(1):17. PubMed ID: 30674312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of statins in chronic obstructive pulmonary disease patients with pulmonary hypertension: A meta-analysis.
    Wang G; Shang W; Ren Y; Liu S; Ren X; Wei S; Han D
    Eur J Intern Med; 2019 Dec; 70():39-42. PubMed ID: 31679886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins and Mortality in COPD: A Methodological Review of Observational Studies.
    Sule NO; Suissa S
    COPD; 2023 Dec; 20(1):284-291. PubMed ID: 37555454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of COPD: moving beyond the lungs.
    Matera MG; Calzetta L; Rinaldi B; Cazzola M
    Curr Opin Pharmacol; 2012 Jun; 12(3):315-22. PubMed ID: 22552103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins in the treatment of COPD and asthma-where do we stand?
    So JY; Dhungana S; Beros JJ; Criner GJ
    Curr Opin Pharmacol; 2018 Jun; 40():26-33. PubMed ID: 29334676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins as adjunct therapy in COPD: how do we cope after STATCOPE?
    Young RP; Hopkins RJ; Agusti A
    Thorax; 2014 Oct; 69(10):891-4. PubMed ID: 25015240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.